Equities

Abingdon Health PLC

ABDX:LSE

Abingdon Health PLC

Health CareMedical Equipment and Services
  • Price (GBX)6.00
  • Today's Change0.00 / 0.00%
  • Shares traded32.11k
  • 1 Year change-22.58%
  • Beta-0.0838
Data delayed at least 20 minutes, as of Feb 06 2026 13:28 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Abingdon Health PLC had net income fall 168.69% from a loss of 1.27m to a larger loss of 3.42m despite a 37.39% increase in revenues from 6.14m to 8.43m. An increase in the cost of goods sold as a percentage of sales from 40.03% to 55.68% was a component in the falling net income despite rising revenues.
Gross margin44.32%
Net profit margin-40.51%
Operating margin-41.63%
Return on assets-47.42%
Return on equity-90.48%
Return on investment-70.70%
More ▼

Cash flow in GBPView more

In 2025, Abingdon Health PLC increased its cash reserves by 33.19%, or 478.00k. Cash Flow from Financing totalled 5.08m or 60.30% of revenues. In addition the company used 3.18m for operations while cash used for investing totalled 1.43m.
Cash flow per share-0.0145
Price/Cash flow per share--
Book value per share0.0274
Tangible book value per share0.013
More ▼

Balance sheet in GBPView more

Abingdon Health PLC has a Debt to Total Capital ratio of 16.25%, a lower figure than the previous year's 41.31%.
Current ratio1.76
Quick ratio1.58
Total debt/total equity0.194
Total debt/total capital0.1625
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.